Literature DB >> 19688727

Gender differences in the use of anxiolytics and antidepressants: a population based study.

J H A Van der Heyden1, L Gisle, E Hesse, S Demarest, S Drieskens, J Tafforeau.   

Abstract

PURPOSE: In the majority of studies on determinants of use of anxiolytics and antidepressants a substantially higher consumption is observed among women than among men. We investigated gender differences in the association between the use of anxiolytics and antidepressants and mental health and explored if there are indications of gender differences in inappropriate use of these medicines.
METHODS: Data were from the 2004 Belgian Health Interview Survey, a nationally representative sample of the Belgian population. The analysis was restricted to the population of 15 years and older (n = 11,220). The probability of use of anxiolytics and antidepressants was assessed through logistic regression models by gender and through models including the interaction between gender and mental health.
RESULTS: The association between the use of antidepressants and mental health did not vary substantially between men and women. Among men the use of anxiolytics showed a strong association with sleeping problems, but not with depressive disorders. Among women the use of anxiolytics was significantly associated with the three mental health conditions that were investigated: depressive disorder, anxiety, and sleeping problems.
CONCLUSIONS: The link between mental health and use of anxiolytics differs by gender. Some indications exist for gender differences in inappropriate use of anxiolytics, whereas this does not hold true for the use of antidepressants. Further efforts are needed to increase the awareness of prescribers, policy makers, and the general public on the appropriate use of anxiolytics, especially among women and in the older population. (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19688727     DOI: 10.1002/pds.1827

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  10 in total

1.  Common and dissociable effects of oxytocin and lorazepam on the neurocircuitry of fear.

Authors:  Ann-Kathrin Kreuder; Dirk Scheele; Johannes Schultz; Juergen Hennig; Nina Marsh; Torge Dellert; Ulrich Ettinger; Alexandra Philipsen; Mari Babasiz; Angela Herscheid; Laura Remmersmann; Ruediger Stirnberg; Tony Stöcker; René Hurlemann
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-08       Impact factor: 11.205

2.  Patterns of depressive symptoms and antidepressant use among women survivors of intimate partner violence.

Authors:  Jinette Comeau; Lorraine Davies
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-12-02       Impact factor: 4.328

3.  Trends in the dispensation of antidepressant drugs over the past decade (2000-2010) in Andalusia, Spain.

Authors:  M C González-López; C M Rodríguez-López; T Parrón-Carreño; J D Luna; E Del Pozo
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-12-20       Impact factor: 4.328

4.  Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017.

Authors:  Johanna Seifert; Fabienne Führmann; Marcel Sieberer; Waldemar Greil; Matthias A Reinhard; Rolf R Engel; Xueqiong Bernegger; Stefan Bleich; Susanne Stübner; Eckart Rüther; Sermin Toto; Renate Grohmann
Journal:  J Neural Transm (Vienna)       Date:  2021-05-11       Impact factor: 3.575

5.  Psychotropic drug use in adolescents born with an orofacial cleft: a population-based study.

Authors:  Sofia Nilsson; Juan Merlo; Viveka Lyberg-Åhlander; Elia Psouni
Journal:  BMJ Open       Date:  2015-04-02       Impact factor: 2.692

6.  Sex differences in drugs: the development of a comprehensive knowledge base to improve gender awareness prescribing.

Authors:  Linnéa Karlsson Lind; Mia von Euler; Seher Korkmaz; Karin Schenck-Gustafsson
Journal:  Biol Sex Differ       Date:  2017-10-24       Impact factor: 5.027

7.  Psychotropic drug use as indicator of mental health in adolescents affected by a plexus injury at birth: A large population-based study in Sweden.

Authors:  Elia Psouni; Raquel Perez Vicente; Lars B Dahlin; Juan Merlo
Journal:  PLoS One       Date:  2018-03-21       Impact factor: 3.240

Review 8.  Gender in Endocrine Diseases: Role of Sex Gonadal Hormones.

Authors:  R Lauretta; M Sansone; A Sansone; F Romanelli; M Appetecchia
Journal:  Int J Endocrinol       Date:  2018-10-21       Impact factor: 3.257

9.  Gender differences in treatment with antidepressants during first weeks of a sick-leave spell due to depressive episode.

Authors:  Per Lytsy; Kristina Alexanderson; Emilie Friberg
Journal:  Eur J Public Health       Date:  2020-04-01       Impact factor: 3.367

10.  Changes in benzodiazepine use in the French general population after November 2015 terrorist attacks in Paris: an interrupted time series analysis of the national CONSTANCES cohort.

Authors:  Clement Gouraud; Guillaume Airagnes; Sofiane Kab; Emilie Courtin; Marcel Goldberg; Frédéric Limosin; Cedric Lemogne; Marie Zins
Journal:  BMJ Open       Date:  2021-09-17       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.